Can elevated Lp(a) and high LDL particle number cause residual cardiovascular risk even when LDL-C is at target?

Elevated levels of lipoprotein(a) [Lp(a)] and a high LDL particle number (LDL-P) represent significant sources of residual cardiovascular risk, persisting even when standard LDL cholesterol (LDL-C) measures are within target ranges. This risk is particularly relevant for older adults, where traditional lipid panels may not fully capture the cumulative atherosclerotic burden.

Clinical evidence of residual risk

Extensive longitudinal data confirms that Lp(a) and LDL-P are independent predictors of cardiovascular events.

• Lipoprotein(a): High Lp(a) (≥50 mg/dL or ≥125 nmol/L) is associated with an increased risk of myocardial infarction and stroke (HR 1.38) even among individuals with very low LDL-C levels.
• LDL Particle Number (LDL-P): Clinical studies demonstrate a "discordance" between LDL cholesterol and particle number. Patients with low LDL-C but high LDL-P remain at high risk (HR 1.11 per standard deviation increase). In these populations, measuring particle number or its proxy, Apolipoprotein B (ApoB), identifies 20-50% more high-risk individuals than standard cholesterol testing alone.

Mechanistic explanations

The risk associated with these markers stems from biological pathways that are not addressed by conventional LDL-C lowering strategies:

• Pro-atherogenic properties: Lp(a) contains a unique protein, apolipoprotein(a), which promotes the transport of oxidized phospholipids into the arterial wall. This triggers inflammation and foam cell formation, accelerating plaque buildup.
• Pro-thrombotic effects: Due to its structural similarity to plasminogen, Lp(a) can interfere with fibrinolysis (clot breakdown), increasing the likelihood of an acute cardiac event if a plaque ruptures.
• Particle burden: While LDL-C measures the weight of cholesterol, LDL-P measures the number of particles. A high LDL-P indicates a greater number of small, dense LDL particles that more easily penetrate the arterial lining and are more susceptible to oxidation.

Bottom line

Standard cholesterol tests may underestimate cardiovascular risk by failing to account for particle concentration and the unique inflammatory properties of Lp(a). In patients who have achieved LDL-C goals but remain at risk, assessing Lp(a) and LDL-P (or ApoB) provides a more precise evaluation of the total atherosclerotic burden.